As per Fact.MR – market research and competitive intelligence provider, the global COVID-19 saliva-based detection kits market was valued at US$ 1.4 Bn in 2020, with demand expected to decline at a CAGR of -2.8% over the forecast period (2021-2031).
COVID-19 is a severe and infectious disease, with diagnosis at the initial stage playing a significant role in stopping the further increase of cases. At present, the old method of sampling, i.e., nasopharyngeal swab is majorly used for testing. However, the emerging technique of saliva-based testing is a promising alternative for COVID-19 diagnosis.
When patients need to get urgent care for more critical flu-like symptoms, physicians need to perform diagnostic tests as soon as possible. To meet this requirement, test kits should be available at cheaper costs, easy to handle, rapid, and equipment-free. This creates an opportunity for market players to come up with innovative devices to fulfil the requirements of patients and physicians in the future.
For More Valuable Information on Regional Market Dynamics, Request a Report Sample –https://www.factmr.com/connectus/sample?flag=S&rep_id=6902
Key Takeaways from Market Study
- By product, PCR-based kits hold around 73.5% value share of the global market in 2021.
- Based on technology, RT-qPCR is leading with 49.2% market share in 2021.
- Based on application, COVID-19 diagnosis is leading with 63.1% market share in 2021.
- By end user, diagnostic laboratories dominate the market with a value share of 26.8% in 2021, while on the other hand, academic and research institutes are expected to increase at a higher CAGR of 2.5%.
- By country, the U.S. dominates the North America market with a value share of 91% in 2021.
“Rising awareness of home-based testing of SARS COV-2 infection and adoption of saliva-based detection as a feasible specimen are expected to drive market growth over the decade,” says a Fact.MR analyst.
What are the Key Opportunities on Offer for COVID-19 Saliva-based Detection Product Manufacturers?
More cases of COVID-19 were observed post-lockdowns after 2-3 months of unlocking due to people not maintaining social distancing at public places. This made the diagnosis of COVID-19 mandatory in many countries.
Furthermore, to break the chain, people became more aware of COVID-19 therapeutic procedures and testing. Individuals who have very mild flu or cough symptoms also do detection tests. As such, demand for COVID-19 testing has increased. For demand fulfilment, RT-PCR is the best method to get a quick and accurate result for COVID-19 infection with the help of saliva.
What Makes the U.S. the Largest Market for COVID-19 Saliva-based Detection Kits?
The U.S. leads the North American region with a market share of 91%, and is projected to continue to do so throughout the forecast period. The U.S. population is focusing on adopting new technology for early detection of SARS-COV-2 Infection with the help of saliva.
The saliva method has various advantages such as cost-effectiveness and non-invasive feature. It has excellent stability and minimal risk of cross-infection. These factors are set to drive demand for COVID-19 saliva-based detection kits in the country.
Why is RT-qPCR Highly Used for COVID-19 Saliva-based Detection?
RT-qPCR dominates the market with 49% revenue. This trend is expected to continue during the study period. High share of this segment is attributed to growing demand for point-of-care testing (POCT).
Real-time diagnoses are rapid results (differs according to the test). They also diagnose current or detect past SARS-CoV-2 infections in various healthcare settings, which, in turn, is driving demand.
What is the Impact of COVID-19 on the Industry?
The COVID-19 pandemic has led to an upsurge in the demand for COVID-19 testing. Furthermore, there is the occurrence of the second wave in certain countries in the last two quarters and the anticipated outbreak of second and third waves across different countries.
Therefore, it can be rightly assumed that COVID-19 saliva-based detection kits will experience further demand growth over the coming years.
For critical insights on this market, request for Methodology here –https://www.factmr.com/connectus/sample?flag=RM&rep_id=6902
Competitive Landscape
Key players are focusing on expansion in emerging regions and new revised product manufacturing. The strategy of acquisition and collaborations by key manufacturers is further strengthening their market presence.
- For instance, in January 2021, Thermo Fisher Scientific acquired Mesa Biotech, a developer of hand-held test devices for COVID-19 detection. This acquisition enabled Thermo Fisher Scientific to accelerate the availability of reliable and accurate advanced molecular diagnostics at the POCT.
- Similarly, recent developments related to companies manufacturing COVID-19 saliva-based detection kits have been tracked by the team at Fact.MR, which are available in the full report.
Key Competitors:
- Thermo Fisher Scientific Inc
- Qiagen
- Hologic
- Takara Bio Inc
- Arcis Biotechnology Limited
- GeneProof
- Abacus ALS
- Kolplast Group
- Vitagene
- Therma Bright Inc
- ACON Laboratories, Inc
- Assure Tech. (Hangzhou) Co., Ltd
- KYODO INTERNATIONAL INC.
- Zymo Research Corporation.
- Salimetrics
Key Segments Covered in COVID-19 Saliva-based Detection Kits Industry Research
By Product
- Rapid Test Kits
- PCR-based Kits
By Technology
- Direct Sample to PCR
- RT-qPCR
- Lateral Flow Assays
By Application
- COVID-19 Research
- COVID-19 Diagnostics
By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic and Research Institutes
- Biopharma Companies
- Long Term Care Facilities
- Home Care Settings
- Others
Key Insights Covered in COVID-19 Saliva-based Detection Kits Industry Survey:
- Market Estimates and Forecasts (2020-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis By Key Players
- Key Product Innovations and Regulatory Climate
- Recommendation on Key Winning Strategies
Get Full Access of this Report through our PayPal Payment Optionhttps://www.factmr.com/checkout/6902
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com